How does stem cell therapy treat multiple sclerosis?

MSCs reduce neuroinflammation, modulate the autoimmune attack on myelin, promote remyelination, and protect neurons from further damage. This can slow disease progression and improve neurological function.

Can stem cells repair myelin damage in MS?

MSCs release neurotrophic factors that support oligodendrocyte function and promote remyelination. While complete myelin repair depends on disease stage, many patients experience measurable neurological improvements.

What MS symptoms improve with stem cell therapy?

Patients report improvements in fatigue, mobility, balance, bladder function, cognitive clarity, and overall quality of life. MRI studies in some cases show reduced lesion activity after MSC treatment.

Is stem cell therapy available for progressive MS?

Yes. We treat both relapsing-remitting MS (RRMS) and progressive forms (PPMS, SPMS). While RRMS patients typically show the strongest response, progressive MS patients can also benefit from the neuroprotective effects of MSC therapy.

Stem Cell Therapy for Multiple Sclerosis (MS): Current Research & Treatment Options

How stem cell therapy addresses multiple sclerosis through immune modulation, neuroprotection, and remyelination. HSCT vs MSC therapy comparison, clinical research, and candidacy criteria.

Understanding MSC Therapy for Multiple Sclerosis

Multiple sclerosis involves both inflammatory demyelination and progressive neurodegeneration. MSC therapy addresses both components: the immunomodulatory properties of MSCs recalibrate the dysregulated immune response, while their neurotrophic factors support remyelination and neuroprotection. This dual mechanism distinguishes MSC therapy from conventional DMTs, which primarily prevent new damage.

RRMS vs Progressive MS: Who Benefits Most?

Clinical evidence is strongest for relapsing-remitting MS (RRMS), where MSC therapy significantly reduces relapse rates and MRI lesion activity. For secondary progressive MS (SPMS) and primary progressive MS (PPMS), benefits focus more on slowing progression and improving symptoms rather than relapse reduction. Individual assessment determines the most appropriate protocol.

MSC vs HSCT for Multiple Sclerosis

HSCT (hematopoietic stem cell transplant) provides a more complete immune reset and is highly effective for aggressive RRMS, but involves chemotherapy conditioning and carries 1-2% mortality risk. MSC therapy is safer (no chemotherapy), suitable for a broader range of patients, and can be repeated safely. HSCT is typically reserved for cases that fail multiple DMTs.

Frequently Asked Questions

How does stem cell therapy treat multiple sclerosis?: MSCs reduce neuroinflammation, modulate the autoimmune attack on myelin, promote remyelination, and protect neurons from further damage. This can slow disease progression and improve neurological function.
Can stem cells repair myelin damage in MS?: MSCs release neurotrophic factors that support oligodendrocyte function and promote remyelination. While complete myelin repair depends on disease stage, many patients experience measurable neurological improvements.
What MS symptoms improve with stem cell therapy?: Patients report improvements in fatigue, mobility, balance, bladder function, cognitive clarity, and overall quality of life. MRI studies in some cases show reduced lesion activity after MSC treatment.
Is stem cell therapy available for progressive MS?: Yes. We treat both relapsing-remitting MS (RRMS) and progressive forms (PPMS, SPMS). While RRMS patients typically show the strongest response, progressive MS patients can also benefit from the neuroprotective effects of MSC therapy.

Stem Cell Therapy for Multiple Sclerosis (MS): Current Research & Treatment Options

Understanding MSC Therapy for Multiple Sclerosis

RRMS vs Progressive MS: Who Benefits Most?

MSC vs HSCT for Multiple Sclerosis

Frequently Asked Questions

Transform Your Health with Regenerative Medicine in Istanbul